AI assistant
Sending…
IRIDEX CORP — Director's Dealing 2015
May 22, 2015
34978_dirs_2015-05-21_0df8c06c-07cf-4e48-a06a-e64dfca1a7c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2015-05-20
Reporting Person: Mackaness James H (CFO and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-20 | Common Stock | M | 2000 | $.90 | Acquired | 44000 | Direct |
| 2015-05-20 | Common Stock | S | 2000 | $9.8045 | Disposed | 42000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-20 | Stock Option Right to Buy | $.90 | M | 2000 | Disposed | 2015-12-11 | Common Stock (2000) | Direct |
Footnotes
F1: The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $9.75 to $9.87 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F2: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
F3: Shares subject to the option are fully vested and exercisable.
More from IRIDEX CORP
Interim / Quarterly Report
2026
May 19
Regulatory Filings
2026
May 19
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Jan 29
Director's Dealing
2026
Jan 28